CB-182804

N/A

Report date: 2023/02/18 10:44:37
NME

Base Information

Drug NameCB-182804
Drug Alias NameCB-182804
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitors
TargetsNot applicable
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiosource
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiosourceCubist Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A